The third clinical trial stage of made-in-Vietnam Covid-19 vaccine Nanocovax is scheduled to start on May 5, three months earlier than expected.

The Institute of Vaccines and Medical Biologicals (IVAC) is recruiting more volunteers aged 40-59 for its Covivac vaccine’s first phase of human trial after having enough volunteers under 40 years old.